Taken together, the restoration of cellularAMPK/mTOR levels and the activation of p62/Nrf-2/HO-1 signal axis miR-100 antagonistic agents strongly support the therapeutic applicability in the AMD. Here, SQSTM1 is linked to age-related macular degeneration.